Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines

Liver Int. 2005 Jun;25(3):633-46. doi: 10.1111/j.1478-3231.2005.01080.x.

Abstract

Background: Lymphotoxin-beta (LT-beta) plays an important role in inflammation and its promoter contains a functional nuclear factor-kappaB (NF-kappaB) element, rendering it a likely target of pro-inflammatory cytokines. Inflammatory cytokines play a central role in liver regeneration resulting from acute or chronic liver injury, with interleukin (IL)-6 signaling essential for liver regeneration induced by partial hepatectomy. In hepatic oval cells observed following chronic liver injury, LT-beta levels are upregulated, suggesting a link between LT-beta and liver regeneration.

Results: The expression of LT-beta in hepatic oval cell and hepatocellular carcinoma cell lines was further investigated, along with its responsiveness to IL-6 and IL-1beta. Key regulatory cis-acting elements of the LT-beta promoter that mediate IL-6 responsiveness (Sp/BKLF, Ets, NF-kappaB and Egr-1/Sp1) and IL-1beta responsiveness (NF-kappaB and Ets) of hepatic LT-beta expression were identified. The novel binding of basic Kruppel-like factor (BKLF) proteins to an apparent composite Sp/BKLF site of the LT-beta promoter was shown to mediate IL-6 responsiveness. Binding of NF-kappaB p65/p50 heterodimers and Ets-related transcription factors to their respective sites mediates responsiveness to IL-1beta.

Conclusion: The identification of IL-6 and IL-1beta as activators of LT-beta supports their involvement in LT-beta signaling in liver regeneration associated with chronic liver damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Carcinoma, Hepatocellular
  • Cell Line, Transformed
  • Cell Line, Tumor
  • DNA-Binding Proteins / metabolism
  • Early Growth Response Protein 1
  • Gene Expression Regulation / drug effects*
  • Gene Expression Regulation / immunology
  • Hepatocytes / cytology
  • Hepatocytes / physiology*
  • Humans
  • Immediate-Early Proteins / metabolism
  • Interleukin-1 / pharmacology*
  • Interleukin-6 / pharmacology*
  • Kruppel-Like Transcription Factors
  • Liver Neoplasms
  • Lymphotoxin-alpha / genetics*
  • Lymphotoxin-alpha / metabolism
  • Lymphotoxin-beta
  • Membrane Proteins / genetics*
  • Membrane Proteins / metabolism
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • NF-kappa B / metabolism
  • NF-kappa B p50 Subunit
  • Promoter Regions, Genetic / genetics
  • Protein Precursors / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-ets
  • Signal Transduction / immunology
  • Sp1 Transcription Factor / metabolism
  • Transcription Factor RelA
  • Transcription Factors / metabolism
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / immunology

Substances

  • DNA-Binding Proteins
  • EGR1 protein, human
  • Early Growth Response Protein 1
  • Immediate-Early Proteins
  • Interleukin-1
  • Interleukin-6
  • KLF3 protein, human
  • Kruppel-Like Transcription Factors
  • LTB protein, human
  • Lymphotoxin-alpha
  • Lymphotoxin-beta
  • Membrane Proteins
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • Protein Precursors
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-ets
  • Sp1 Transcription Factor
  • Transcription Factor RelA
  • Transcription Factors